Mesoblast Ltd
NASDAQ: MESO
$7.50
+$0.21 (+2.9%)
Closing price May 3, 2024
MESO Chart and Intraday Price
MESO Company Data
| Asset Type | Common Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Address | LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, AU |
| Fiscal Year End | June |
| Latest Quarter | 2023-06-30 |
| Market Cap | 596.70M USD |
| Shares Outstanding | 101,480,000 |
MESO Articles
Mesoblast shares more than doubled on Friday after the company provided an update on its COVID-19 treatment. Should it be taken with a grain of salt?
Published:
More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at some of the biggest movers on the day tied to COVID-19.
Published: